Integrating Health Solutions for Diabetes in Micronesia
GrantID: 15003
Grant Funding Amount Low: $3,750,000
Deadline: Ongoing
Grant Amount High: $3,750,000
Summary
Explore related grant categories to find additional funding opportunities aligned with this program:
Education grants, Health & Medical grants, Research & Evaluation grants, Science, Technology Research & Development grants.
Grant Overview
Eligibility Barriers in The Federated States of Micronesia
Applicants in The Federated States of Micronesia face distinct eligibility barriers tied to the nation's unique status under the Compact of Free Association with the United States. This agreement governs access to federal grants, but imposes restrictions not encountered by mainland entities. For instance, FSM entities must demonstrate direct ties to U.S.-affiliated health research frameworks, often requiring endorsements from the FSM Department of Health and Social Affairs. Without such validation, applications risk disqualification, as federal funders scrutinize Compact compliance to prevent fund diversion.
A primary barrier stems from cohort recruitment challenges in FSM's dispersed geography. Spanning four statesYap, Chuuk, Pohnpei, and Kosraeacross 607 islands in the vast western Pacific, the total population hovers around 115,000. Building a longitudinal cohort for diabetes post-SARS-CoV-2 demands sustained participant tracking, yet inter-island travel relies on infrequent ferries and costly flights, inflating logistical hurdles. Entities proposing studies must prove capacity for multi-year retention rates above federal benchmarks, typically 80%, amid high emigration to Guam or Hawaii. Failures here trigger ineligibility, as seen in prior Pacific health studies where attrition exceeded 40% due to mobility.
Sovereign status adds layers: FSM applicants cannot claim U.S. statehood benefits, facing caps on indirect cost rates limited to 26% under Compact rules. Proposals exceeding this, even for legitimate overhead like remote data storage, face rejection. Health & Medical organizations in FSM must also navigate dual regulatory oversightnational laws and U.S. federal requirementsrisking barriers if protocols omit FSM-specific informed consent in local languages like Chuukese or Kosraean.
Compliance Traps for FSM Applicants
Compliance traps abound in FSM's regulatory landscape, particularly for this diabetes cohort study. A frequent pitfall involves Institutional Review Board (IRB) approvals. FSM lacks a centralized IRB equivalent to U.S. models; instead, approvals route through state health departments or regional bodies like the Pacific Islands Health Officers Association. Delays arise when applicants submit U.S.-centric IRB forms, ignoring FSM's decentralized structure. For example, Yap State's Department of Health Services requires separate ethical reviews for outer island protocols, and misalignment leads to application holds.
Data security compliance poses another trap. Federal grants mandate HIPAA-equivalent protections, but FSM's infrastructuredependent on satellite internet with frequent outagesstruggles with secure electronic health records. Applicants bypassing hybrid paper-digital systems risk non-compliance flags. Moreover, exporting de-identified data to U.S. servers, as in collaborations with Rhode Island research hubs, triggers export control reviews under Compact terms, delaying timelines by months.
Budget compliance ensnares many: Direct costs capped at $3.75 million for FY2023 and FY2026 demand precise justification. FSM applicants often overlook Compact-mandated audits by the U.S. Government Accountability Office, where unallocated funds for Research & Evaluation components invite clawbacks. Science, Technology Research & Development tie-ins, such as genomic sequencing for diabetes cohorts, must exclude proprietary tech transfers without U.S. Treasury approval, a trap for Pacific-focused applicants.
Participant diversity requirements form a subtle trap. Grants prioritize cohorts reflecting SARS-CoV-2 exposure patterns, but FSM's low testing rates during peaksdue to reagent shortagesundermine baseline data. Proposals failing to address this with retrospective serology face compliance scrutiny, especially when benchmarking against higher-incidence areas like Kentucky.
Exclusions: What This Grant Does Not Fund
This grant strictly limits funding to longitudinal cohort establishment for post-SARS-CoV-2 diabetes. Routine diabetes screening programs receive no support, nor do general COVID-19 surveillance efforts. Treatment interventions, such as insulin distribution or clinic upgrades, fall outside scopeapplicants proposing these face outright rejection.
Basic epidemiological surveys without longitudinal follow-up are excluded; one-time cross-sectional studies do not qualify. Infrastructure builds, like new labs in Pohnpei, or staff training absent cohort-specific protocols, draw no funds. Education components, even in Health & Medical curricula at the College of Micronesia-FSM, must tie directly to cohort management or risk defunding.
Geographic expansions beyond FSM cohorts, such as comparative arms in neighboring Marshall Islands without explicit justification, violate focus. Indirect costs for unrelated administrative overhead, or contingencies for typhoon disruptions not cohort-integrated, are ineligible. Finally, retrospective-only analyses post-2026 lack support; ongoing tracking through FY2026 remains mandatory.
Q: Can FSM applicants include retrospective data collection in their cohort plans? A: No, the grant excludes purely retrospective designs; applications must prioritize prospective longitudinal enrollment starting from active SARS-CoV-2 cases to meet federal specificity for post-infection diabetes tracking.
Q: What happens if an FSM proposal references U.S. state IRBs without local state health department input? A: It triggers compliance review delays or rejection, as FSM Department of Health and Social Affairs endorsements are required to align with Compact protocols and ensure culturally appropriate consent processes.
Q: Are funds available for diabetes prevention education in FSM outer islands? A: No, this grant does not fund prevention or education initiatives; support is confined to the defined longitudinal cohort study on diabetes development following SARS-CoV-2 infection.
Eligible Regions
Interests
Eligible Requirements
Related Grants
Grants Supporting Capacity Building for Latino History Museums
Unlock transformative funding opportunities designed to enhance the capacity of museums dedicated to...
TGP Grant ID:
72051
Annual Grant Supporting Long-Form Literary and Arts Writing
Unlock a transformative funding opportunity designed specifically for writers engaged in substantial...
TGP Grant ID:
75945
Grants for Culturally Specific Services
Grant supports the maintenance and replication of existing successful services in dating violence, d...
TGP Grant ID:
63924
Grants Supporting Capacity Building for Latino History Museums
Deadline :
Ongoing
Funding Amount:
Open
Unlock transformative funding opportunities designed to enhance the capacity of museums dedicated to American Latino history and culture. This initiat...
TGP Grant ID:
72051
Annual Grant Supporting Long-Form Literary and Arts Writing
Deadline :
Ongoing
Funding Amount:
$0
Unlock a transformative funding opportunity designed specifically for writers engaged in substantial long-form creative expression. The Silvers Grants...
TGP Grant ID:
75945
Grants for Culturally Specific Services
Deadline :
2024-05-02
Funding Amount:
$0
Grant supports the maintenance and replication of existing successful services in dating violence, domestic violence, sexual assault, and stalking com...
TGP Grant ID:
63924